ICD-10 Code D06.0 | Carcinoma in situ of endocervix Symptoms, Diagnosis, Billing

Carcinoma in situ of the endocervix is a pre-invasive form of cervical cancer characterized by abnormal cell growth confined to the epithelial layer of the cervix. It is primarily caused by persistent infection with high-risk human papillomavirus (HPV) types. Accurate coding with ICD-10 Code D06.0 is essential for proper diagnosis, documentation, medical billing, and public health reporting, facilitating appropriate patient management and resource allocation.

What is ICD-10 Code D06.0 for Carcinoma in situ of endocervix?

ICD-10 Code D06.0 represents Carcinoma in situ of the endocervix, indicating the presence of abnormal cells that have not invaded deeper tissues. This code is used in clinical documentation and billing when diagnosing patients with this pre-cancerous condition, ensuring accurate representation of the patient's health status and guiding treatment decisions.

ICD-10 Code D06.0 – Clinical Definition and Explanation of Carcinoma in situ of endocervix

Carcinoma in situ of the endocervix is a significant precursor to invasive cervical cancer, often linked to high-risk HPV infections. Early detection and intervention are crucial to prevent progression to invasive disease. This condition requires medical attention due to its potential for malignancy.

Key Clinical Features:

• Abnormal cervical cytology results (e.g., Pap smear)
• Presence of high-risk HPV types
• Asymptomatic in early stages, may present with abnormal bleeding later
• Increased incidence in women aged 30-50 years
• Requires regular monitoring and potential surgical intervention

ICD-10 Code D06.0 for Carcinoma in situ of endocervix – SOAP Notes & Clinical Use

ICD-10 Code D06.0 is utilized in SOAP notes to document the diagnosis of Carcinoma in situ of the endocervix. It plays a vital role in recording patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code D06.0 for Carcinoma in situ of endocervix Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D06.0 connects subjective patient reports and objective clinical findings to a formal diagnosis of Carcinoma in situ of the endocervix. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D06.0 – Carcinoma in situ of endocervix

Management of Carcinoma in situ of the endocervix typically involves surgical intervention, as the condition is not infectious. Prompt treatment is necessary to prevent progression to invasive cancer.

Antibiotic Therapy:

Supportive Care:

• Regular follow-up with gynecological examinations
• Patient education on HPV vaccination and screening
• Psychosocial support for anxiety related to diagnosis

Infection Control:

How to Document Symptoms of Carcinoma in situ of endocervix (ICD-10 D06.0) in SOAP Notes

Subjective:

• Patient reports abnormal Pap smear results.
• No significant symptoms reported; denies pelvic pain or bleeding.
• History of HPV infection noted.
• Patient expresses concern about cancer risk.

Objective:

• Cervical examination reveals no visible lesions.
• Pap smear results indicate high-grade squamous intraepithelial lesion (HSIL).
• Colposcopy findings suggestive of carcinoma in situ.
• HPV typing confirms presence of high-risk HPV.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Carcinoma in situ of endocervix (ICD-10 Code D06.0)

Assessment:

• Diagnosis: Carcinoma in situ of endocervix (ICD-10 D06.0).
• Severity: Pre-invasive lesion with potential for progression.
• Contributing factors: High-risk HPV infection.
• Regular monitoring required to assess for progression.

Plan:

• Refer for surgical evaluation (e.g., LEEP or cone biopsy).
• Educate patient on HPV vaccination and screening importance.
• Schedule follow-up appointments for monitoring.
• Provide resources for emotional support.

Treatment & Plan Section for ICD-10 Code D06.0 – Carcinoma in situ of endocervix

• Surgical intervention (e.g., LEEP or excisional biopsy) is the primary treatment.
• Patient education on HPV prevention and regular screenings.
• Psychological support services may be beneficial.
• Follow-up care to monitor for recurrence or progression.

Using ICD-10 Code D06.0 for Carcinoma in situ of endocervix in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Use D06.0 in appropriate clinical settings to support billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document any related procedures or consultations for comprehensive coding.

Related ICD-10 Codes Often Used with Carcinoma in situ of endocervix

• D06.1 – Carcinoma in situ of exocervix
• D06.9 – Carcinoma in situ of cervix, unspecified
• C53.0 – Invasive carcinoma of endocervix
• C53.1 – Invasive carcinoma of exocervix

ICD-10 Code D06.0 in Medical Billing and Insurance for Carcinoma in situ of endocervix

ICD-10 Code D06.0 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use D06.0 in conjunction with procedure codes for surgical interventions.
• Ensure compliance with payer-specific guidelines for documentation.
• Maintain clear records of patient education and follow-up care.

Common CPT Pairings: